Sales/Maturities of Investments

$2.15B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$2.15Bperiod endingJun 30, 2026

REGN Quarterly Sales/Maturities of Investments ($32.30M → $2.15B)

Quarterly Sales/Maturities of Investments

High-resolution chart · PNG

REGN sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Sales/Maturities of Investments — Quarterly (USD)
Period ending	Sales/Maturities of Investments (USD)
Jun 30, 2001	28,257,000
Mar 31, 2001	23,908,000
Dec 31, 2000	15,813,000
Sep 30, 2000	2,798,000
Jun 30, 2000	24,842,000
Mar 31, 2000	10,264,000
Dec 31, 1999	8,800,000
Sep 30, 1999	14,900,000
Jun 30, 1999	25,800,000
Mar 31, 1999	33,700,000
Dec 31, 1998	17,700,000
Sep 30, 1998	27,700,000
Jun 30, 1998	25,800,000
Mar 31, 1998	22,300,000
Dec 31, 1997	27,000,000
Sep 30, 1997	18,500,000
Jun 30, 1997	10,800,000
Mar 31, 1997	19,600,000
Dec 31, 1996	8,200,000
Sep 30, 1996	10,500,000
Jun 30, 1996	10,700,000
Mar 31, 1996	9,500,000
Dec 31, 1995	12,200,000
Sep 30, 1995	1,400,000
Jun 30, 1995	11,200,000
Mar 31, 1995	14,000,000
Dec 31, 1994	9,500,000
Sep 30, 1994	9,400,000
Jun 30, 1994	19,600,000
Mar 31, 1994	22,800,000
Dec 31, 1993	18,900,000
Sep 30, 1993	16,100,000
Jun 30, 1993	18,400,000
Mar 31, 1993	15,100,000
Dec 31, 1992	23,600,000
Sep 30, 1992	33,900,000
Jun 30, 1992	13,400,000
Mar 31, 1992	11,900,000
Dec 31, 1991	27,400,000
Sep 30, 1991	32,300,000